Accrued expenses consisted of the following as of March 31, 2023, and December 31, 2022 (in thousands):
March 31,
December 31,
2023
2022
Accrued research and development
$
31,510
34,849
Accrued royalties
1,558
907
Accrued payroll liabilities
24,189
43,212
Other
13,994
16,171
Total
71,251
95,139
No definition available.
Tabular disclosure of the components of accrued liabilities.